Randomised study: Belotero Intense lip filler achieved a response in 91% of patients
The Aesthetic Surgery Journal published a multicentre randomised study of Belotero Intense with lidocaine for lip augmentation.
The Aesthetic Surgery Journal published a multicentre randomised study of Belotero Intense with lidocaine for lip augmentation.
The FDA sent warning letters dated 1 October 2026 over genital herpes products sold on Amazon and Walmart.
On 9 October 2026 the FDA approved Hovilpri (pritelivir) tablets for herpes simplex lesions in immunocompromised adults.
On 8 October 2026 the FDA approved Tecentriq (atezolizumab) with chemotherapy as adjuvant treatment for stage III colon cancer.
The CDC reported on a botulinum toxin product not approved by the FDA that was used at a Colorado medical spa.
On 7 October 2026 the FDA approved Tukysa (tucatinib) with trastuzumab and pertuzumab as maintenance for advanced HER2-positive breast cancer.
On 2 October 2026 the FDA approved Jaypirca (pirtobrutinib) for adults with previously untreated chronic lymphocytic leukemia.
The FDA has published new information warning about clear aligners sold directly to consumers.
Nothing more to show